Universe · entity
Omega Fund Management, LLC
Institutional manager (13F) · CIK 1637359
13F holdings · as of 2026-03-31 · top 10 · reported portfolio $163M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | Bicara Therapeutics Inc. | $48M | 2,392,150 |
| 2 | Nuvation Bio Inc. | $35M | 8,081,089 |
| 3 | BridgeBio Oncology Therapeutics Inc. | $29M | 3,289,661 |
| 4 | Kestra Med Technologies Ltd | $20M | 1,022,149 |
| 5 | Beta Bionics Inc. | $13M | 1,316,183 |
| 6 | enGene Holdings Inc. | $6M | 876,357 |
| 7 | Alumis Inc. | $5M | 241,255 |
| 8 | Sana Biotechnology, Inc. | $2M | 843,750 |
| 9 | ImageneBio, Inc. | $2M | 455,361 |
| 10 | Replimune Group | $2M | 248,672 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.